M-A | Efficacy and tolerability of cranial electrotherapy stimulation in the treatment of anxiety.
20 Jul, 2022 | 11:42h | UTC
Commentary on Twitter
MA: cranial electrotherapy stimulation, a portable device, reduced anxiety symptoms vs. control group [g= −0.625; −0.952 to −0.298]. CES reduced both primary and secondary anxiety (g= −1.218 and −0.334, respectively). No severe AEs were reported https://t.co/Z9f9vnvmVD pic.twitter.com/wyN91oz7Mi
— PfOL (@psychopharmacol) June 15, 2022